SciClone Pharmaceuticals, Inc. Hosts Thymalfasin Symposium at Asian Pacific Association for the Study of the Liver

FOSTER CITY, CA--(Marketwire - March 17, 2008) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to host a symposium at the 18th annual meeting of the Asian Pacific Association for the Study of the Liver (APASL), in Seoul, Korea on Tuesday, March 25, 2008.
MORE ON THIS TOPIC